119 related articles for article (PubMed ID: 27994751)
1. Identification of
Wu Z; Lu Y; Li L; Zhao R; Wang B; Lv K; Liu M; You X
ACS Med Chem Lett; 2016 Dec; 7(12):1130-1133. PubMed ID: 27994751
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
Tang J; Wang B; Wu T; Wan J; Tu Z; Njire M; Wan B; Franzblauc SG; Zhang T; Lu X; Ding K
ACS Med Chem Lett; 2015 Jul; 6(7):814-8. PubMed ID: 26191372
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y
Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507
[TBL] [Abstract][Full Text] [Related]
6. Identification of Pyrazolo[1,5-
Hu X; Wan B; Liu Y; Shen J; Franzblau SG; Zhang T; Ding K; Lu X
ACS Med Chem Lett; 2019 Mar; 10(3):295-299. PubMed ID: 30891129
[TBL] [Abstract][Full Text] [Related]
7. Identification of
Li L; Lv K; Yang Y; Sun J; Tao Z; Wang A; Wang B; Wang H; Geng Y; Liu M; Guo H; Lu Y
ACS Med Chem Lett; 2018 Jul; 9(7):741-745. PubMed ID: 30034611
[TBL] [Abstract][Full Text] [Related]
8. Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.
Lv K; You X; Wang B; Wei Z; Chai Y; Wang B; Wang A; Huang G; Liu M; Lu Y
ACS Med Chem Lett; 2017 Jun; 8(6):636-641. PubMed ID: 28626525
[TBL] [Abstract][Full Text] [Related]
9. Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.
Moraski GC; Markley LD; Hipskind PA; Boshoff H; Cho S; Franzblau SG; Miller MJ
ACS Med Chem Lett; 2011 Jun; 2(6):466-470. PubMed ID: 21691438
[TBL] [Abstract][Full Text] [Related]
10. Advancement of Imidazo[1,2-
Moraski GC; Markley LD; Cramer J; Hipskind PA; Boshoff H; Bailey M; Alling T; Ollinger J; Parish T; Miller MJ
ACS Med Chem Lett; 2013 Jul; 4(7):675-679. PubMed ID: 23930153
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
[TBL] [Abstract][Full Text] [Related]
13. Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and "Anagrams" Generated Potent Antituberculosis Agents.
Moraski GC; Miller PA; Bailey MA; Ollinger J; Parish T; Boshoff HI; Cho S; Anderson JR; Mulugeta S; Franzblau SG; Miller MJ
ACS Infect Dis; 2015 Feb; 1(2):85-90. PubMed ID: 25984566
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Fluorine-Containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis.
Zhao H; Lu Y; Sheng L; Yuan Z; Wang B; Wang W; Li Y; Ma C; Wang X; Zhang D; Huang H
ACS Med Chem Lett; 2017 May; 8(5):533-537. PubMed ID: 28523106
[TBL] [Abstract][Full Text] [Related]
15. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
[TBL] [Abstract][Full Text] [Related]
16. Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.
Nallangi R; Samala G; Sridevi JP; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Apr; 76():110-7. PubMed ID: 24583350
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-
Khetmalis YM; Chitti S; Umarani Wunnava A; Karan Kumar B; Murali Krishna Kumar M; Murugesan S; Chandra Sekhar KVG
RSC Med Chem; 2022 Mar; 13(3):327-342. PubMed ID: 35434623
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J
Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715
[TBL] [Abstract][Full Text] [Related]
19. Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
Lu X; Tang J; Cui S; Wan B; Franzblauc SG; Zhang T; Zhang X; Ding K
Eur J Med Chem; 2017 Jan; 125():41-48. PubMed ID: 27654393
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
